Document Detail


Xg expression in Ewing's sarcoma is of prognostic value and contributes to tumor invasiveness.
MedLine Citation:
PMID:  20388798     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ewing's sarcoma (EWS) is an aggressive tumor of children and young adults that requires intensive treatment. The search for new prognostic factors is very important to choose the most appropriate therapy and to better understand the biology of the disease for the development of new therapeutic tools. We found that Xg, a thus far poorly described molecule and member of the CD99 family, is expressed in EWS cell lines and EWS primary tumors. Immunohistochemical analysis confirmed the expression of Xg in 24% of patients. We found that Xg expression in EWS defines a subgroup of patients with worse prognosis compared with those with Xg-negative localized tumors, indicating a clinical relevance of Xg expression in EWS. Forced expression of Xg in an EWS cell line upregulated cell migration and invasion in vitro. Furthermore, knockdown of Xg expression with specific short hairpin RNA significantly reduced migration and invasion of EWS cells. Consistent with these data, in vivo xenotransplant studies in nude mice revealed that Xg expression increased the incidence and the number of metastases of EWS cells. Thus, Xg expression is associated with lower overall survival in EWS patients with localized tumors and is implicated in metastasis.
Authors:
Oph?lie Meynet; Katia Scotlandi; Emmanuelle Pradelli; Maria C Manara; Mario P Colombo; Heidy Schmid-Antomarchi; Piero Picci; Alain Bernard; Ghislaine Bernard
Related Documents :
15287028 - Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply con...
16204038 - Expression of the ews/fli-1 oncogene in murine primary bone-derived cells results in ew...
19890408 - Soft tissue tumors: new perspectives on classification and diagnosis.
12049818 - The af2 domain of the orphan nuclear receptor tec is essential for the transcriptional ...
11228478 - Role of androgens in the growth of endometrial carcinoma: an in vivo animal model.
15926078 - 90y labeling of monoclonal antibody mov18 and preclinical validation for radioimmunothe...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-04-13
Journal Detail:
Title:  Cancer research     Volume:  70     ISSN:  1538-7445     ISO Abbreviation:  Cancer Res.     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-04-30     Completed Date:  2010-05-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2984705R     Medline TA:  Cancer Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3730-8     Citation Subset:  IM    
Copyright Information:
(c)2010 AACR.
Affiliation:
Institut National de la Sante et de la Recherche Medicale UMR 576 and CHU Nice, Hopital de l'Archet, Laboratoire d'Immunologie, Nice, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Animals
Blood Group Antigens / biosynthesis*
Bone Neoplasms / immunology,  metabolism,  pathology
Cell Adhesion Molecules / biosynthesis*
Cell Line, Tumor
Cell Movement / physiology
Child
Female
Humans
Lung Neoplasms / immunology,  metabolism,  secondary
Male
Mice
Mice, Nude
Neoplasm Invasiveness
Osteosarcoma / immunology,  metabolism,  pathology
Prognosis
Sarcoma, Ewing's / immunology,  metabolism*,  pathology
Chemical
Reg. No./Substance:
0/Blood Group Antigens; 0/Cell Adhesion Molecules; 0/XG protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Microphthalmia-Associated Transcription Factor Controls the DNA Damage Response and a Lineage-Specif...
Next Document:  Tobacco and Cancer: An American Association for Cancer Research Policy Statement.